Home

recinto Centro di produzione Melodrammatico aasld poster guidelines concorrenti cappotto Richiamare

The Liver Meeting® Abstract Submission Guide
The Liver Meeting® Abstract Submission Guide

PosterSessionOnline
PosterSessionOnline

VBI Vaccines Announces Late-Breaker Poster Presentation at The Liver  Meeting® 2019 - VBI Vaccines
VBI Vaccines Announces Late-Breaker Poster Presentation at The Liver Meeting® 2019 - VBI Vaccines

Baylor Scott & White Presents At AASLD – The Liver Meeting 2022
Baylor Scott & White Presents At AASLD – The Liver Meeting 2022

Should patients with clinically significant portal hypertension be on  beta-blockers? | AASLD
Should patients with clinically significant portal hypertension be on beta-blockers? | AASLD

Xiaochen Liu presents a poster AASLD 2019 in Boston, MA
Xiaochen Liu presents a poster AASLD 2019 in Boston, MA

Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding than  Propranolol for Secondary Prophylaxis | AASLD
Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding than Propranolol for Secondary Prophylaxis | AASLD

PosterSessionOnline
PosterSessionOnline

Abstract Submission Guidelines - Digestive Disease Week (DDW)
Abstract Submission Guidelines - Digestive Disease Week (DDW)

The Liver Meeting® Abstract Submission Guide
The Liver Meeting® Abstract Submission Guide

Median Technologies on X: "Our latest scientific poster presented at the  AASLD Liver meeting that took place from Nov 13-16, is now online here:  https://t.co/nnyWCiEcDU #mediantechnologies #ibiopsy #liverdisease  #radiomics #AIforhealth https://t.co ...
Median Technologies on X: "Our latest scientific poster presented at the AASLD Liver meeting that took place from Nov 13-16, is now online here: https://t.co/nnyWCiEcDU #mediantechnologies #ibiopsy #liverdisease #radiomics #AIforhealth https://t.co ...

Post AASLD Reflection | Perspectum
Post AASLD Reflection | Perspectum

LiverLearning®: "Best Of" Series
LiverLearning®: "Best Of" Series

Does the addition of rifaximin to lactulose improve outcomes in overt  hepatic encephalopathy? | AASLD
Does the addition of rifaximin to lactulose improve outcomes in overt hepatic encephalopathy? | AASLD

Hepatology
Hepatology

Naim Alkhouri on LinkedIn: #mash #masld
Naim Alkhouri on LinkedIn: #mash #masld

LiverLearning®: The Liver Meeting Digital Experience ™
LiverLearning®: The Liver Meeting Digital Experience ™

Fibronostics on LinkedIn: #aasld2023 #fibronostics #liverhealth  #researchbreakthroughs #liverfast
Fibronostics on LinkedIn: #aasld2023 #fibronostics #liverhealth #researchbreakthroughs #liverfast

The Liver Meeting® Abstract Submission Guide
The Liver Meeting® Abstract Submission Guide

Is 4 days enough time to assess response in patients receiving steroids for  severe alcohol-related hepatitis? | AASLD
Is 4 days enough time to assess response in patients receiving steroids for severe alcohol-related hepatitis? | AASLD

The Liver Meeting - iPoster Sessions - Production
The Liver Meeting - iPoster Sessions - Production

AASLD opportunities and support - NMRI Meeting - April 2016 | PPT
AASLD opportunities and support - NMRI Meeting - April 2016 | PPT

ePoster Upload Instructions
ePoster Upload Instructions

Abstract submissions for #DDW2024 are now open! View submission guidelines  at ddw.org/education/abstracts and submit yours by Nov. 30.… | Instagram
Abstract submissions for #DDW2024 are now open! View submission guidelines at ddw.org/education/abstracts and submit yours by Nov. 30.… | Instagram

Covert HE and Sleep Disturbances in Cirrhosis | AASLD
Covert HE and Sleep Disturbances in Cirrhosis | AASLD